http://www.foresight.org/nanodot/?p=1965 examining transformative technology Wed, 03 Apr 2013 18:23:47 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.foresight.org/nanodot/?p=1965#comment-858146 Mon, 15 Jun 2009 00:18:44 +0000 http://www.foresight.org/nanodot/?p=1965#comment-858146 I don I don

]]> http://www.foresight.org/nanodot/?p=1965#comment-836237 Thu, 23 Apr 2009 12:33:36 +0000 http://www.foresight.org/nanodot/?p=1965#comment-836237 I usually don I usually don

]]> http://www.foresight.org/nanodot/?p=1965#comment-5326 Brock Hinzmann Thu, 30 Jun 2005 07:30:17 +0000 http://www.foresight.org/nanodot/?p=1965#comment-5326 The attidute of the insurance industry will certainly be important for many industries in the adoption of any new technology, including nanotech. Basically, whoo will pay if something goes wrong. The current U.S. administration is trying to lower the liability limits for companies developing new technologies and products. It needs to be shown that a company acted irresponsibly and that the users of the product had no reason to have any knowledge of risks associated with using it. Even if a company doesn't advertise the risks, consumers need to show common sense, too. I wwould be curious to see how something like stem cell therapies (which might involved nanomaterials in various ways) will be viewed by insurance companies, if a benefit is shown to be life saving in most cases, but to have some detrimental side effects in other cases. The attidute of the insurance industry will certainly be important for many industries in the adoption of any new technology, including nanotech. Basically, whoo will pay if something goes wrong. The current U.S. administration is trying to lower the liability limits for companies developing new technologies and products. It needs to be shown that a company acted irresponsibly and that the users of the product had no reason to have any knowledge of risks associated with using it. Even if a company doesn’t advertise the risks, consumers need to show common sense, too. I wwould be curious to see how something like stem cell therapies (which might involved nanomaterials in various ways) will be viewed by insurance companies, if a benefit is shown to be life saving in most cases, but to have some detrimental side effects in other cases.

]]>